Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104045
Filing Date
2025-08-06
Accepted
2025-08-06 16:13:51
Documents
68
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q artv-20250630.htm   iXBRL 10-Q 3144373
2 EX-31.1 artv-ex31_1.htm EX-31.1 13113
3 EX-31.2 artv-ex31_2.htm EX-31.2 13133
4 EX-32.1 artv-ex32_1.htm EX-32.1 14040
  Complete submission text file 0000950170-25-104045.txt   10686692

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT artv-20250630.xsd EX-101.SCH 1312252
71 EXTRACTED XBRL INSTANCE DOCUMENT artv-20250630_htm.xml XML 1918213
Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Filer) CIK: 0001817241 (see all company filings)

EIN.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42179 | Film No.: 251189738
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)